FCGR3A and neoplasm: Tribody [(HER2)2xCD16] specifically bound HER2-positive tumor cells (Figure 3C) and CD16-expressing NK cells as well as γδ T cells (Figure 3D), but not antigen-negative cells such as Raji or αβ T cells (Figures 3C,D).